Serum HER2 extracellular domain predicts an aggressive clinical outcome and biological PSA response in hormone-independent prostate cancer patients treated with docetaxel
Titel:
Serum HER2 extracellular domain predicts an aggressive clinical outcome and biological PSA response in hormone-independent prostate cancer patients treated with docetaxel
Auteur:
Domingo-Domenech, J. Fernandez, P.L. Filella, X. Martinez-Fernandez, A. Molina, R. Fernandez, E. Alcaraz, A. Codony, J. Gascon, P. Mellado, B.